Works matching DE "CYTARABINE"

Results: 1257

The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety.

Published in:

Drugs, 2025, v. 85, n. 7, p. 855, doi. 10.1007/s40265-025-02194-w

By:

Pagano, Livio;
Danesi, Romano;
Benedetti, Edoardo;
Morgagni, Riccardo;
Romani, Luigina;
Venditti, Adriano

Publication type:

Article

Development of a Novel Biomarker Platform for Profiling Key Protein–Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1852, doi. 10.3390/cancers17111852

By:

Kinloch, Andrew J.;
Rahman, Faiyaz;
Karakas, Bahriye;
Shahid, Muhammad;
Lim, Bora;
Bouley, Stephanie J.;
Walker, James A.;
Lee, Erinna F.;
Fairlie, Walter D.;
Kelly, Kevin R.;
Cardone, Michael H.

Publication type:

Article

TP53‐Mutated Acute Myeloid Leukemia: Review of Treatment and Challenges.

Published in:

European Journal of Haematology, 2025, v. 114, n. 6, p. 924, doi. 10.1111/ejh.14404

By:

Ghimire, Bipin;
Zimmer, Markie;
Donthireddy, Vijayalakshmi

Publication type:

Article

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.

Published in:

2007

By:

Stegmaier, Kimberly;
Wong, Jenny S.;
Ross, Kenneth N.;
Chow, Kwan T.;
Peck, David;
Wright, Renee D.;
Lessnick, Stephen L.;
Kung, Andrew L.;
Golub, Todd R.

Publication type:

journal article

Treatment of myeloid neoplasia with doxorubicin and cytarabine in 11 dogs.

Published in:

Veterinary & Comparative Oncology, 2023, v. 21, n. 1, p. 54, doi. 10.1111/vco.12860

By:

Matsuyama, Arata;
Beeler‐Marfisi, Janet;
Wood, R. Darren;
Richardson, Danielle;
Calvalido, Jerome;
Mutsaers, Anthony J.;
Bienzle, Dorothee

Publication type:

Article

Evaluation of a multi‐agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non‐Hodgkin high‐grade lymphomas: a single centre's experience.

Published in:

Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 165, doi. 10.1111/vco.12457

By:

Smallwood, Katherine;
Tanis, Jean‐Benoit;
Grant, Iain A.;
Blackwood, Laura;
Killick, David R.;
Amores‐Fuster, Isabel;
Elliott, James;
Mas, Aran;
Harper, Aaron;
Marrington, Mary;
Finotello, Riccardo

Publication type:

Article

A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E144, doi. 10.1111/vco.12360

By:

Elliott, J.;
Finotello, R.

Publication type:

Article

Safety of intrathecal administration of cytosine arabinoside and methotrexate in dogs and cats.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 3, p. 331, doi. 10.1111/vco.12109

By:

Genoni, S.;
Palus, V.;
Eminaga, S.;
Cherubini, G. B.

Publication type:

Article

Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 2, p. 181, doi. 10.1007/s00228-017-2355-7

By:

Yang, Xia;
Liu, Wei;
Lyons, Allie;
Song, Zaiwei;
Zhai, Suodi;
Hu, Kai

Publication type:

Article

Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 3, p. 293, doi. 10.1007/s00228-014-1795-6

By:

He, Hui;
Yin, Jiye;
Li, Xi;
Zhang, Yu;
Xu, Xiaojing;
Zhai, Ming;
Chen, Juan;
Qian, Chenyue;
Zhou, Honghao;
Liu, Zhaoqian

Publication type:

Article

Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia.

Published in:

Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01425-w

By:

Nair, Ramya;
Salinas-Illarena, Alejandro;
Sponheimer, Monika;
Wullkopf, Inès;
Schreiber, Yannick;
Côrte-Real, João Vasco;
del Pozo Ben, Augusto;
Marterer, Helena;
Thomas, Dominique;
Geisslinger, Gerd;
Cinatl Jr., Jindrich;
Subklewe, Marion;
Baldauf, Hanna-Mari

Publication type:

Article

Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents.

Published in:

2016

By:

Cragg, Gordon M.;
Pezzuto, John M.

Publication type:

journal article

Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma.

Published in:

Medical Principles & Practice, 2010, v. 19, n. 5, p. 344, doi. 10.1159/000316370

By:

Kanat, Ozkan;
Ozet, Ahmet;
Ataergın, Selmin;
Arpacı, Fikret;
Kuzhan, Okan;
Komurcu, Seref;
Ozturk, Bekir;
Ozturk, Mustafa

Publication type:

Article

Clinical efficacy and immune response of BCL-2 inhibitors combined with hypomethylating agents in the treatment of acute myeloid leukemia.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01348-8

By:

Peng, Xiaohuan;
Yu, Jianing;
Tang, Futian;
Li, Yanhong;
Bai, Jun;
Li, Lijuan;
Zhang, Liansheng

Publication type:

Article

CSRP1 gene: a potential novel prognostic marker in acute myeloid leukemia with implications for immune response.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01088-9

By:

Zhao, Chunxia;
Wang, Yulu;
Wang, Huan;
Sharma, Amit;
Wu, Yun;
Schmidt-Wolf, Ingo G. H.;
Wang, Zifeng

Publication type:

Article

Chemotherapy resistance in acute myeloid leukemia is associated with decreased anti-tumor immune response through MHC molecule and B7 family members.

Published in:

Discover Oncology, 2024, p. 1, doi. 10.1007/s12672-024-01072-3

By:

Ge, Jing;
Yin, Xiaoxuan;
Sun, Xin;
Kou, Liduo;
Xue, Xin;
Ma, Juan

Publication type:

Article

Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.

Published in:

JAMA Network Open, 2024, v. 7, n. 5, p. e2411726, doi. 10.1001/jamanetworkopen.2024.11726

By:

Lamba, Jatinder K.;
Marrero, Richard;
Wu, Huiyun;
Cao, Xueyuan;
Parcha, Phani Krisha;
Karol, Seth E.;
Inaba, Hiroto;
Kuo, Dennis John;
Degar, Barbara A.;
Heym, Kenneth;
Taub, Jeffrey W.;
Lacayo, Norman J.;
Pui, Ching-Hon;
Ribeiro, Raul C.;
Pounds, Stanley B.;
Rubnitz, Jeffrey E.

Publication type:

Article

Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia.

Published in:

Regenerative Biomaterials, 2022, v. 9, p. 1, doi. 10.1093/rb/rbac058

By:

Wu, Hao;
Gao, Yuan;
Ma, Jia;
Hu, Maosong;
Xia, Jing;
Bao, Shuting;
Liu, Yuxi;
Feng, Kai

Publication type:

Article

Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives.

Published in:

Journal of Liposome Research, 2015, v. 25, n. 2, p. 166, doi. 10.3109/08982104.2014.950277

By:

Papachristos, Apostolos;
Pippa, Natassa;
Ioannidis, Konstantinos;
Sivolapenko, Gregory;
Demetzos, Costas

Publication type:

Article

Tribulus terrestris L. Hydroalcoholic Extract Revokes the Hepatotoxicity Induced by Cytarabine in Male Wistar Rats.

Published in:

Pharmaceutical & Biomedical Research, 2025, v. 11, n. 1, p. 13, doi. 10.32598/PBR.11.1.1307.2

By:

Darbandi, Niloufar;
Jabbar, Ruba Fadhel

Publication type:

Article

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients.

Published in:

2019

By:

Horibata, Sachi

Publication type:

Opinion

Effect of arsenic trioxide plus etoposide, solumedrol, high‑dose cytarabine and cisplatin chemotherapy on the treatment of relapsed or ref7ractory ALK+ anaplastic large cell lymphoma.

Published in:

Oncology Letters, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/ol.2023.13854

By:

Ding, Yi;
Lu, Huina;
Dong, Yan;
Xiu, Bing;
Liang, Aibin;
Zhang, Wenjun

Publication type:

Article

Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with RAS mutations.

Published in:

Oncology Letters, 2021, v. 22, n. 5, p. N.PAG, doi. 10.3892/ol.2021.13006

By:

Park, Jihyun;
Park, Hyejoo;
Byun, Ja Min;
Hong, Junshik;
Shin, Dong-Yeop;
Koh, Youngil;
Yoon, Sung-Soo

Publication type:

Article

miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells.

Published in:

Oncology Letters, 2021, v. 21, n. 2, p. 1, doi. 10.3892/ol.2020.12380

By:

LIANG ZHANG;
LI YU;
YIRAN LIU;
SHASHA WANG;
ZHENFENG HOU;
JUN ZHOU

Publication type:

Article

Immunological effects of a low‑dose cytarabine, aclarubicin and granulocyte‑colony stimulating factor priming regimen on a mouse leukemia model.

Published in:

Oncology Letters, 2018, v. 16, n. 3, p. 3022, doi. 10.3892/ol.2018.9018

By:

ChEN, Jinqiu;
Yang, Nan;
Liu, Hailing;
Yao, Huan;
Wang, Jin;
Yang, Yun;
Zhang, Wanggang

Publication type:

Article

Novel homobarringtonie‑containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy.

Published in:

Oncology Letters, 2017, v. 14, n. 6, p. 7597, doi. 10.3892/ol.2017.7084

By:

Jingsong He;
Li Li;
Jingjing Zhu;
Weiyan Zheng;
Wenjun Wu;
Yanlong Zheng;
Xiujin Ye

Publication type:

Article

A patient with chronic myeloid leukemia and situs inversus totalis: A case report.

Published in:

2017

By:

Yunxia Sun;
Xiaoli Li;
Lijun Li;
Huan Liu;
Qian Xu;
Bei Liu

Publication type:

Case Study

Transverse myelopathy occurring with intrathecal administration of methotrexate and cytarabine chemotherapy: A case report.

Published in:

2016

By:

YING PAN;
CHUNHUAI WANG;
HUIPING WANG;
QIANSHAN TAO;
SHUDAO XIONG;
ZHIMIN ZHAI

Publication type:

Case Study

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB.

Published in:

Oncology Letters, 2016, v. 11, n. 1, p. 355, doi. 10.3892/ol.2015.3876

By:

FENG XIAO;
YING LI;
WEILAI XU;
LIANGSHUN YOU;
CHUNMEI YANG;
HUI LIU;
WENBIN QIAN

Publication type:

Article

Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report.

Published in:

Oncology Letters, 2015, v. 10, n. 1, p. 422, doi. 10.3892/ol.2015.3247

By:

KUI SONG;
XIAOJUN XU;
MIN LI

Publication type:

Article

Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case report.

Published in:

Oncology Letters, 2015, v. 9, n. 3, p. 1217, doi. 10.3892/ol.2015.2870

By:

QI DENG;
JING-YI LI;
PENG-JIANG LIU;
MING-FENG ZHAO

Publication type:

Article

Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.

Published in:

Molecular & Clinical Oncology, 2017, v. 6, n. 3, p. 384, doi. 10.3892/mco.2017.1134

By:

SANTO, ANA ESPIRITO;
CHACIM, SERGIO;
FERREIRA, ISABEL;
LEITE, LUIS;
MOREIRA, CLAUDIA;
PEREIRA, DULCINEIA;
DANTAS, MARGARIDA;
NUNES, MARTA;
VITERBO, LUISA;
MOREIRA, ILIDIA;
MARTINS, ANGELO;
OLIVEIRA, ISABEL;
DOMINGUES, NELSON;
MARIZ, JOSE;
MEDEIROS, RUI

Publication type:

Article

Cyclophosphamide combined with mitoxantrone and cytarabine is an effective salvage regimen for patients with acute myeloid leukemia who experienced primary induction failure or relapse.

Published in:

Molecular & Clinical Oncology, 2016, v. 4, n. 2, p. 285, doi. 10.3892/mco.2015.679

By:

SHUNING WEI;
YINGCHANG MI;
HUI WEI;
DONG LIN;
KANQI LIU;
BENFA GONG;
GUANGJI ZHANG;
YUNTAO LIU;
YAN LI;
CHUNLIN ZHOU;
BINGCHENG LIU;
WEI LI;
JIANXIANG WANG

Publication type:

Article

Immunochemotherapy for primary central nervous system lymphoma with rituximab, methotrexate, cytarabine and dexamethasone: Retrospective analysis of 18 cases.

Published in:

Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 209, doi. 10.3892/mco.2015.566

By:

JING LIU;
XUE-FEI SUN;
JUN QIAN;
XUE-YAN BAI;
HONG ZHU;
QU CUI;
XIAO-YAN LI;
YUE-DAN CHEN;
YA-MING WANG;
YUAN-BO LIU

Publication type:

Article

Asymmetric Anterior Uveitis as a Delayed Complication of Treatment with Systemic High-dose Cytosine-Arabinoside: A Case Report and Literature Review.

Published in:

Ocular Immunology & Inflammation, 2014, v. 22, n. 4, p. 322, doi. 10.3109/09273948.2013.801990

By:

Grewal, Dilraj S.;
Holland, Peter M.;
Frankfurt, Olga;
Pyatetsky, Dmitry

Publication type:

Article

Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes.

Published in:

ImmunoTargets & Therapy, 2023, v. 12, p. 135, doi. 10.2147/ITT.S429402

By:

Jiang, Jiqian;
Wang, Yan;
Liu, Dan;
Wang, Xiaoyu;
Zhu, Yingqiao;
Tong, Juan;
Chen, Erling;
Xue, Lei;
Zhao, Na;
Liang, Tingting;
Zheng, Changcheng

Publication type:

Article

Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovir.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1385, doi. 10.1038/bmt.2015.159

By:

Camus, V;
Bouwyn, J-P;
Chamseddine, A;
Lenain, P;
Ahtoy, P;
Stamatoullas, A;
Lanic, H;
Lemasle, E;
Contentin, N;
Cassuto, O;
Leprêtre, S;
Dubois, S;
Tilly, H;
Jardin, F

Publication type:

Article

Outcomes of EAM conditioned autologous haematopoietic SCT for lymphoma. A matched pairs retrospective single-centre study analysis.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1486, doi. 10.1038/bmt.2013.90

By:

Loke, J;
Ward, J;
Mahendra, P;
Chaganti, S;
Malladi, R

Publication type:

Article

Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1082, doi. 10.1038/bmt.2011.218

By:

Ahmadi, T;
McQuade, J;
Porter, D;
Frey, N;
Loren, A W;
Goldstein, S C;
Svoboda, J;
Stadtmauer, E;
Schuster, S J;
Nasta, S D

Publication type:

Article

Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.

Published in:

Bone Marrow Transplantation, 2011, v. 46, n. 7, p. 923, doi. 10.1038/bmt.2010.243

By:

Kato, J.;
Mori, T.;
Yokoyama, K.;
Tsukada, Y.;
Ueda, T.;
Shimizu, T.;
Okamoto, S.

Publication type:

Article

Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 7, p. 1147, doi. 10.1038/bmt.2009.318

By:

Musso, M.;
Scalone, R.;
Marcacci, G.;
Lanza, F.;
Di Renzo, N.;
Cascavilla, N.;
Di Bartolomeo, P.;
Crescimanno, A.;
Perrone, T.;
Pinto, A.

Publication type:

Article

Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.

Published in:

Bone Marrow Transplantation, 2009, v. 44, n. 12, p. 785, doi. 10.1038/bmt.2009.83

By:

Zohren, F.;
Czibere, A.;
Bruns, I.;
Fenk, R.;
Schroeder, T.;
Gräf, T.;
Haas, R.;
Kobbe, G.

Publication type:

Article

ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non- Hodgkin's Lymphoma.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2025, v. 19, n. 2, p. 151

By:

Dehghani, Mehdi;
Vojdani, Reza;
Khalafi-Nezhad, Abolfazl;
Ravanbod, Mohammad Reza;
Ramzi, Mani;
Dehdashti, Shima;
Namdari, Nasrin

Publication type:

Article

Evaluating the Efficacy of Modified BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2023, v. 17, n. 2, p. 106

By:

Ramzi, Mani;
Vafaie, Elaheh;
Haghighinejad, Hourvash;
Imran, Hashim

Publication type:

Article

Comparison of Long-Acting G-CSF (PD-Lasta) with Short-Acting G-CSF (PD-Grastim) in Neutrophil Recovery Following Consolidation Chemotherapy with High-Dose Cytarabine in Acute Myeloid Leukemia: A Randomized Clinical Trial.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2021, v. 15, n. 2, p. 96

By:

Esfandbod, Mohsen;
Bararzadeh, Fatemeh Agha;
Faraz, Mona;
Zarrabi, Fariba;
Toogeh, Gholamreza

Publication type:

Article

Fever and skin lesions in an immunocompromised patient.

Published in:

Clinical & Experimental Dermatology, 2015, v. 40, n. 2, p. 219, doi. 10.1111/ced.12483

By:

del Alcazar, E.;
Jaka, A.;
Camino, N.;
Gancho, G.;
Tuneu, A.

Publication type:

Article

Trends of drug shortages in China from 2018 to 2020: A retrospective observational study.

Published in:

Journal of Global Health, 2024, v. 14, p. 1, doi. 10.7189/jogh.14.04225

By:

Tao Huang;
Lin Bai;
Huangqianyu Li;
Hao Li;
Zhiyuan Wang;
Luwen Shi;
Xiaodong Guan

Publication type:

Article

Progressive Multifocal Leukoencephalopathy after Three Consecutive Liver Transplantations.

Published in:

2015

By:

Ozdemir, F.;
Ince, V.;
Baskiran, A.;
Ozdemir, Z.;
Bayindir, Y.;
Otlu, B.;
Yilmaz, S.

Publication type:

Case Study

Glasdegib: First Global Approval.

Published in:

Drugs, 2019, v. 79, n. 2, p. 207, doi. 10.1007/s40265-018-1047-7

By:

Hoy, Sheridan M.

Publication type:

Article

Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia.

Published in:

Drugs, 2018, v. 78, n. 18, p. 1911, doi. 10.1007/s40265-018-1034-z

By:

Blair, Hannah A.

Publication type:

Article